SIC 2834 – Pharmaceutical Preparations
Valuation | |
---|---|
Market Cap ($M) | n/a |
Enterprise Value ($M) | n/a |
Book Value ($M) | 70.22 |
Book Value / Share | 3.56 |
Price / Book | n/a |
NCAV ($M) | -45.62 |
NCAV / Share | -2.31 |
Price / NCAV | n/a |
Profitability (mra) | |
---|---|
Return on Invested Capital (ROIC) | -2.93 |
Return on Assets (ROA) | -0.97 |
Return on Equity (ROE) | -2.03 |
Liquidity (mrq) | |
---|---|
Quick Ratio | 0.96 |
Current Ratio | 1.11 |
Balance Sheet (mrq) ($M) | |
---|---|
Current Assets | 161.58 |
Assets | 277.42 |
Liabilities | 207.20 |
Debt | n/a |
Equity | n/a |
Income Statement (mra) ($M) | |
---|---|
Revenue | 0.00 |
Operating Income | 0.00 |
Net Income | 0.00 |
Cash Flow Statement (mra) ($M) | |
---|---|
Cash From Operations | 0.00 |
Cash from Investing | 0.00 |
Cash from Financing | 0.00 |
(click for more detail) |
File Date | Form | Activist 13D/G Investors | Ownership (%) |
Change (%) |
---|---|---|---|---|
13D/A | Zentree Investments Ltd | 18.20 | 13.85 | |
13D/A | ABeeC 2.0, LLC | 21.90 | 0.00 | |
13D/A | Glaxosmithkline Plc | 9.50 | -95.00 | |
13G/A | Sc Us (ttgp), Ltd. | 3.90 | -95.00 |
Top 13F Investors | Shares (1000) |
Change (%) |
Value ($1000) |
Change (%) |
---|---|---|---|---|
(click for more detail) |
Date | Insider Trades | Code | Shares | Value |
---|---|---|---|---|
(click for more detail) |
Similar Companies | |
---|---|
MDCLF – MedinCell S.A. | MDIN – MedGen, Inc. |
MDRM – Modern Mobility Aids, Inc. | MEOBF – Mesoblast Limited |
MITPF – Mithra Pharmaceuticals SA |
Financial data and stock pages provided by
Fintel.io